According to the newly released announcement dated 9 February 2026, Biosino Bio-Technology and Science Incorporation has approved a comprehensive set of Rules of Procedure for its Board of Directors at an extraordinary general meeting. The document, consisting of six chapters, details the composition of the Board, procedures for convening and conducting meetings, voting mechanisms, and record retention requirements.

The announcement states that the Board shall comprise at least seven directors, with independent directors making up no less than one-third of the total. The Board is responsible for matters including convening shareholders’ meetings, preparing operating plans, managing investments, and overseeing profit distribution proposals. Extraordinary Board meetings may be called at the request of shareholders representing more than one-tenth of voting rights, or one-third of the directors.

Under these Rules of Procedure, directors are expected to attend Board meetings in person or through authorized proxies, and the quorum for a meeting is a majority of the directors. If a director fails to attend two consecutive meetings (either in person or by proxy), the Board may recommend removal. Voting procedures specify that each director has one vote, with decisions requiring a majority unless abstentions or specific conflicts of interest apply.

The document further emphasizes proper documentation practices, mandating that minutes of every Board meeting, relevant notices, and voting results be retained for at least ten years. The Rules of Procedure also clarify that detailed decision-making materials must be made available to directors in advance, ensuring that discussions are thorough and that resolutions, especially concerning finances and major transactions, adhere to legal and regulatory standards.